Andrew Thomas King

6PUBLICATIONS
58CO-AUTHORS
Molecular targetsAutoimmunityHaematologyStylistics and textual analysisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma.

Adam P Jones, Michael J Haley, Miriam H Meadows

|Mar 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).

Peter J Hutchinson, Ellie Edlmann, John G Hanrahan

|Mar 07, 2024
Reported Hearing Outcome Measures Following Stereotactic Radiosurgery for Vestibular Schwannoma: A Scoping Review.

Ibrahim Almufarrij, Cathal John Hannan, Andrew Thomas King

|Apr 01, 2022
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.

D Gareth Evans, Stefania Mostaccioli, David Pang

|Jan 24, 2022
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants.

Daniel Moualed, Jonathan Wong, Owen Thomas

Pageof 1